Loading chat...
NY A04945
Bill
Status
2/27/2023
Primary Sponsor
Phillip Steck
Click for details
AI Summary
-
Requires all health insurance policies providing medical or major medical coverage to include coverage for non-opioid pain management treatments, including drugs, biological products, and implantable or reusable medical devices that can replace or reduce opioid use.
-
Applies mandate to individual policies (Insurance Law § 3216), group and blanket policies (§ 3221), and contracts issued by medical expense indemnity corporations and health service corporations (§ 4303).
-
Allows insurers to impose annual deductibles and co-insurance on non-opioid treatments consistent with other benefits in the policy, subject to superintendent approval.
-
Directs the commissioner of social services to establish standards and guidelines for providing non-opioid pain management treatments under the Medicaid program, in consultation with providers and interested parties.
-
Takes effect 120 days after enactment and applies to all policies and contracts issued, renewed, modified, altered, or amended on or after the effective date.
Legislative Description
Requires health insurers to provide coverage for non-opioid treatments utilized for pain management including, but not limited to a drug or biological product that is indicated to produce analgesia without acting upon the body's opioid receptors that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed; or an implantable, reusable, or disposable medical device for the intended use of managing or treating pain that has demonstrated the ability to replace, reduce, or avoid opioid use or the quantity of opioids prescribed.
Last Action
referred to insurance
1/3/2024